01 March 2019
Claas Kirchhelle and co-authors propose a joint, internationally-funded antimicrobial development institute that would fund permanent staff to take on roles previously assigned to pharmaceutical companies. The concept for antimicrobial development aims to maximise society’s investment, through open science, investment in people, and the sharing of intellectual property while overcoming the continuing issue of economic incentive.
Public vs Private Bodies: Who Should Run Advanced AI Evaluations and Audits? A Three-Step Logic Based on Case Studies of High-Risk Industries
The Dublin Declaration fails to recognize the need to reduce industrial animal agriculture
Open Problems in Technical AI Governance
Integrating Physical Climate Risks and Adaptation into Sovereign Credit Ratings
The Future of International Scientific Assessments of AI’s Risks
Impacts of climate change-related human migration on infectious diseases
If you found this page useful, sign up to our monthly digest of the latest news and events
Subscribe